13
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Piebaldism with Neurofibromatosis Type I: A Familial Case

      letter

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Dear Editor: Piebaldism is characterized by the congenital absence of melanocytes in affected areas of the skin and hair due to a mutation of the c-kit proto-oncogene, which affects melanoblast differentiation and migration1. This mutation is inherited as an autosomal dominant trait. Clinically, piebaldism is characterized by stable, persistent, and well-circumscribed depigmented patches that are present at birth and symmetrically affectthe face, trunk, and extremities. Hyperpigmented macules are typically noted on both depigmented and unaffected adjacent skin. A white forelock of hair appears in 80% to 90% of cases2. Neurofibromatosis type 1 (NF-1) is an autosomal dominant neurocutaneous disorder that is characterized by multiple café-au-lait macules, neurofibromas, or both3. A 5-year-old boy had a white forelock and depigmented patches over the abdomen and extremities since birth. Physical examination revealed islands of pigmented macules within these leukodermic patches. He also had numerous café-au-lait macules on the trunk and extremities, at least six of which were > 5 mm in diameter (Fig. 1). The diagnosis of NF-1 is based on clinical criteria established by the National Institutes of Health Consensus Conference in 1987. According to these criteria, two or more of the following findings establish the diagnosis of NF-1; six or more café-au-lait macules > 5 mm in diameter in pre-pubertal individuals and > 15 mm in diameter after puberty; two or more neurofibromas or one plexiform neurofibroma; freckling in the axillary or inguinal regions; optic pathway tumor; distinctive bone lesions such as sphenoid wing dysplasia; and a first-degree relative with NF-13. Our patient satisfied the diagnostic criteria. Skin biopsies were obtained from a depigmented lesion and a café-au-lait macule on the abdomen. Basal hyperpigmentation was noticed in the café-au-lait macule only. Fontana-Masson staining of the depigmented area was negative, while that of the café-au-lait macule revealed increased melanin pigments in the basal layer. No S-100-positive dendritic epidermal cells were detected in the leukodermic area, while some were detected in the pigmented macule (Fig. 2). Family history revealed inheritance of piebaldism on the paternal side: the father was affected with a white forelock and several depigmented patches. In addition, the patient's mother referred to a paternal aunt and grandmother with similar depigmented patches (Fig. 2G). Among them, however, only his father had concomitant numerous café-au-lait macules. Based on the clinical and histological findings, we diagnosed this patient with piebaldism and NF-1. To date, the co-occurrence of piebaldism and NF-1 has been described in only six patients including ours4,5. Piebaldism and NF-1 genes have been cloned and assigned to different chromosomes (4q12 and 17q11.2, respectively). Based on genetic and prevalence data, the co-occurrence of piebaldism and NF-1 appears most likely random. However, these two hereditary disorders are commonly related with abnormal melanocyte development and differentiation. By discovering additional genetic abnormalities and pathogeneses related to these disorders, we may be able to ensure early diagnosis, adequate follow-up, and genetic counseling for affected patients.

          Related collections

          Most cited references5

          • Record: found
          • Abstract: not found
          • Article: not found

          Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            A novel KIT mutation results in piebaldism with progressive depigmentation.

            Piebaldism is an autosomal dominant disorder of melanocyte development characterized by white skin (leukoderma) and white hair (poliosis). In general, piebaldism has been distinguished from vitiligo by the presence of lesions from birth, the hyperpigmented macules of depigmented and normal skin, and the static course. We hypothesized that an 8-year-old girl and her mother who had unusual piebaldism of a progressive nature would have a novel mutation of the KIT gene, the gene that is altered in patients with piebaldism, or of the MITF (microphthalmia activating transcription factor) gene, which would be expected to cause type II Waardenburg syndrome, but is associated with a phenotype of progressive depigmentation in mice. Genomic DNA was extracted from the blood of affected and unaffected family members, and the KIT and MITF genes were sequenced. Genetic analysis of genomic DNA from both the mother and daughter with progressive piebaldism revealed a novel Val620Ala (1859T>C) mutation in the KIT gene, which was not detected in family members without progressive piebaldism or in 52 normal control individuals. This KIT mutation affects the intracellular tyrosine kinase domain and thus predicts a severe phenotype, as was the case in this family. Although other KIT mutations in the vicinity of codon 620 lead to the standard phenotype of static piebaldism, the Val620Ala mutation is novel and may result in a previously undescribed phenotype with melanocyte instability, leading to progressive loss of pigmentation as well as the progressive appearance of the hyperpigmented macules.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Piebaldism: an update.

                Bookmark

                Author and article information

                Journal
                Ann Dermatol
                Ann Dermatol
                AD
                Annals of Dermatology
                Korean Dermatological Association; The Korean Society for Investigative Dermatology
                1013-9087
                2005-3894
                April 2014
                30 April 2014
                : 26
                : 2
                : 264-266
                Affiliations
                Department of Dermatology, Yonsei University Wonju College of Medicine, Wonju, Korea.
                [1 ]Department of Dermatology, Atopy and Asthma Center, Seoul Medical Center, Seoul, Korea.
                Author notes
                Corresponding author: Sung Ku Ahn, Department of Dermatology, Yonsei University Wonju College of Medicine, 20 Ilsan-ro, Wonju 220-701, Korea. Tel: 82-33-741-0621, Fax: 82-33-748-2650, ahnsk@ 123456yonsei.ac.kr
                Article
                10.5021/ad.2014.26.2.264
                4037687
                24882989
                ddfa2a96-d42b-484b-a01d-942bb24b0c76
                Copyright © 2014 The Korean Dermatological Association and The Korean Society for Investigative Dermatology

                This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 22 November 2012
                : 09 April 2013
                : 24 April 2013
                Categories
                Letter to the Editor

                Dermatology
                Dermatology

                Comments

                Comment on this article